About Align Technology (NASDAQ:ALGN)
Align Technology, Inc. designs, manufactures and markets a system of clear aligner therapy, intra-oral scanners and computer-aided design/computer-aided manufacturing (CAD/CAM) digital services used in dentistry, orthodontics and dental records storage. The Company operates through two segments: Clear Aligner segment and Scanner and Services (Scanner) segment. The Clear Aligner segment consists of its Invisalign System, which includes Invisalign Full, Teen and Assist (Comprehensive Products), Express/Lite (Non-Comprehensive Products) and Vivera Retainers, along with its training and ancillary products for treating malocclusion (Non-Case). The Scanner segment consists of intra-oral scanning systems and other services available with the intra-oral scanners that provide digital alternatives to the traditional cast models. The Scanner segment includes its iTero scanner and OrthoCAD services.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Equipment, Supplies & Distribution
- Sub-Industry: Health Care Supplies
- Symbol: NASDAQ:ALGN
- CUSIP: 01625510
- Web: www.aligntech.com
- Market Cap: $16.10073 billion
- Outstanding Shares: 80,150,000
- 50 Day Moving Avg: $187.02
- 200 Day Moving Avg: $157.72
- 52 Week Range: $83.27 - $201.70
Sales & Book Value:
- Trailing P/E Ratio: 68.79
- Foreward P/E Ratio: 49.11
- P/E Growth: 2.37
- Annual Revenue: $1.24 billion
- Price / Sales: 12.98
- Book Value: $13.45 per share
- Price / Book: 14.94
- EBITDA: $306.55 million
- Net Margins: 19.18%
- Return on Equity: 23.87%
- Return on Assets: 16.93%
- Current Ratio: 2.36%
- Quick Ratio: 2.28%
- Average Volume: 927,894 shs.
- Beta: 1.54
- Short Ratio: 3.31
Frequently Asked Questions for Align Technology (NASDAQ:ALGN)
What is Align Technology's stock symbol?
Align Technology trades on the NASDAQ under the ticker symbol "ALGN."
How were Align Technology's earnings last quarter?
Align Technology, Inc. (NASDAQ:ALGN) announced its earnings results on Thursday, July, 27th. The company reported $0.85 EPS for the quarter, topping the consensus estimate of $0.73 by $0.12. The firm had revenue of $356.50 million for the quarter, compared to the consensus estimate of $343.43 million. Align Technology had a net margin of 19.18% and a return on equity of 23.87%. The business's quarterly revenue was up 32.3% on a year-over-year basis. During the same quarter last year, the firm posted $0.62 EPS. View Align Technology's Earnings History.
When will Align Technology make its next earnings announcement?
What guidance has Align Technology issued on next quarter's earnings?
Align Technology issued an update on its third quarter earnings guidance on Thursday, July, 27th. The company provided earnings per share guidance of $0.79-0.82 for the period, compared to the Thomson Reuters consensus estimate of $0.79. The company issued revenue guidance of $355-360 million, compared to the consensus revenue estimate of $341.95 million.
Where is Align Technology's stock going? Where will Align Technology's stock price be in 2017?
10 brokerages have issued 12 month price targets for Align Technology's stock. Their predictions range from $150.00 to $230.00. On average, they anticipate Align Technology's share price to reach $198.50 in the next twelve months. View Analyst Ratings for Align Technology.
What are analysts saying about Align Technology stock?
Here are some recent quotes from research analysts about Align Technology stock:
- 1. According to Zacks Investment Research, "Align Technology’s second-quarter 2017 performance was promising with it beating the Zacks Consensus Estimate on both the fronts. We are encouraged by the company’s strong InvisAlign Technology prospects and growth in North America and international regions. Management particularly expects consistent growth in the Asia-Pacific region. To note, the company has recently opened a new InvisAlign Technology Treatment Planning facility in China. We are also upbeat about the multi-million dollar marketing campaign for promoting InvisAlign Technology brand. The company’s receipt of two U.S. patents for SmartTrack Aligner material buoys optimism. Notably, over the past one month, Align Technology has been trading above the industry. On the flip side, a strong dollar continues to act as a dampener. Also high consts and expenses weigh on margins. Moreover, tough competition and macroeconomic headwinds are other concerns." (8/21/2017)
- 2. Leerink Swann analysts commented, "healthy" (6/26/2017)
Who are some of Align Technology's key competitors?
Some companies that are related to Align Technology include Zimmer Biomet Holdings (ZBH), C.R. Bard (BCR), DENTSPLY SIRONA (XRAY), Steris Plc (STE), West Pharmaceutical Services (WST), Bio-Rad Laboratories (BIO), Hill-Rom Holdings (HRC), VWR Corporation (VWR), Integra LifeSciences Holdings Corporation (IART), DexCom (DXCM), ICU Medical (ICUI), LivaNova PLC (LIVN), Neogen Corporation (NEOG), NuVasive (NUVA), Nevro Corp. (NVRO), Haemonetics Corporation (HAE), Halyard Health (HYH) and Inogen (INGN).
Who are Align Technology's key executives?
Align Technology's management team includes the folowing people:
- Charles Raymond Larkin Jr., Independent Chairman of the Board
- Joseph M. Hogan, President, Chief Executive Officer, Director
- John F. Morici, Chief Financial Officer
- Emory M. Wright, Vice President - Operations
- Roger E. George, Vice President - Corporate and Legal Affairs and General Counsel
- Simon Beard, Vice President, Managing Director - EMEA
- Jennifer Olson, Vice President and Managing Director - Doctor Directed Consumer Channel
- Christopher C. Puco, Vice President, Managing Director - North America
- Julie Tay, Vice President, Managing Director - Asia Pacific
- Stuart Hockridge, Vice President - Global Human Resources
Who owns Align Technology stock?
Align Technology's stock is owned by many different of institutional and retail investors. Top institutional investors include Fisher Asset Management LLC (0.11%), Robeco Institutional Asset Management B.V. (0.11%), APG Asset Management N.V. (0.06%), State Treasurer State of Michigan (0.03%), Sit Investment Associates Inc. (0.03%) and Mutual of America Capital Management LLC (0.01%). Company insiders that own Align Technology stock include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, David C Nagel, David L White, Emory Wright, George J Morrow, Greg J Santora, Jennifer Erfurth, Jennifer Olson, Joseph Lacob, Julie Tay, Raphael Pascaud, Roger E George, Sreelakshmi Kolli, Thomas M Prescott, Timothy A Mack, Warren S Thaler and Zelko Relic. View Institutional Ownership Trends for Align Technology.
Who sold Align Technology stock? Who is selling Align Technology stock?
Align Technology's stock was sold by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Mutual of America Capital Management LLC, State Treasurer State of Michigan, Meeder Asset Management Inc., Sit Investment Associates Inc. and Robeco Institutional Asset Management B.V.. Company insiders that have sold Align Technology stock in the last year include Andrea Lynn Saia, C Raymond Larkin Jr, Christopher C Puco, David L White, Jennifer Olson, Joseph Lacob, Sreelakshmi Kolli, Thomas M Prescott and Warren S Thaler. View Insider Buying and Selling for Align Technology.
Who bought Align Technology stock? Who is buying Align Technology stock?
How do I buy Align Technology stock?
Shares of Align Technology can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Align Technology's stock price today?
MarketBeat Community Rating for Align Technology (NASDAQ ALGN)MarketBeat's community ratings are surveys of what our community members think about Align Technology and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Align Technology stock can currently be purchased for approximately $200.88.
Consensus Ratings for Align Technology (NASDAQ:ALGN) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||10 Buy Ratings|
|Consensus Rating:||Buy (Score: 3.00)|
|Consensus Price Target: ||$198.50 (1.18% downside)|Consensus Price Target History for Align Technology (NASDAQ:ALGN)
Analysts' Ratings History for Align Technology (NASDAQ:ALGN)
(Data available from 10/22/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|10/19/2017||Stifel Nicolaus||Reiterated Rating||Buy||N/A|
|10/18/2017||Robert W. Baird||Set Price Target||Buy||$208.00||N/A|
|10/10/2017||Northcoast Research||Reiterated Rating||Buy||$200.00 -> $230.00||N/A|
|10/6/2017||Morgan Stanley||Reiterated Rating||Overweight||$195.00 -> $220.00||N/A|
|9/15/2017||Goldman Sachs Group, Inc. (The)||Boost Price Target||Buy||$185.00 -> $210.00||Low|
|9/11/2017||Piper Jaffray Companies||Reiterated Rating||Buy||$200.00||Medium|
|7/28/2017||Leerink Swann||Reiterated Rating||Outperform||$194.00 -> $199.00||Low|
|7/28/2017||Bank of America Corporation||Upgrade||Neutral -> Buy||$175.00 -> $193.00||High|
|7/13/2017||Credit Suisse Group||Reiterated Rating||Outperform||$140.00 -> $170.00||Low|
|6/1/2017||Jefferies Group LLC||Reiterated Rating||Buy||$150.00||Low|
|3/24/2016||Canaccord Genuity||Reiterated Rating||Buy||$72.00 -> $80.00||N/A|
|3/23/2016||Roth Capital||Boost Price Target||Buy||$72.00 -> $80.00||N/A|
|1/29/2016||William Blair||Reiterated Rating||Buy||N/A|
Earnings History for Align Technology (NASDAQ:ALGN)Earnings History by Quarter for Align Technology (NASDAQ ALGN)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|7/27/2017||Q2 2017||$0.73||$0.85||$343.43 million||$356.50 million||View||N/A|
|4/27/2017||Q1 2017||$0.67||$0.85||$297.46 million||$310.34 million||View||N/A|
|1/31/2017||Q416||$0.66||$0.59||$292.75 million||$293.20 million||View||N/A|
|11/7/2016||Q3||$0.52||$0.63||$271.61 million||$278.60 million||View||Listen|
|7/28/2016||Q2||$0.48||$0.62||$259.29 million||$269.40 million||View||Listen|
|4/28/2016||Q116||$0.40||$0.50||$236.22 million||$238.70 million||View||Listen|
|1/28/2016||Q415||$0.52||$0.60||$226.68 million||$230.30 million||View||Listen|
|10/22/2015||Q315||$0.34||$0.34||$205.10 million||$207.64 million||View||Listen|
|7/23/2015||Q215||$0.37||$0.39||$209.14 million||$209.50 million||View||Listen|
|4/23/2015||Q115||$0.32||$0.38||$190.89 million||$198.10 million||View||N/A|
|1/29/2015||Q414||$0.49||$0.48||$198.10 million||$198.60 million||View||N/A|
|10/23/2014||Q314||$0.43||$0.47||$188.70 million||$189.90 million||View||Listen|
|7/24/2014||Q214||$0.39||$0.43||$185.80 million||$192.53 million||View||N/A|
|4/23/2014||Q114||$0.35||$0.39||$177.57 million||$180.60 million||View||N/A|
|1/31/2014||Q413||$0.43||$0.51||$172.24 million||$178.30 million||View||N/A|
|10/17/2013||Q313||$0.30||$0.42||$158.64 million||$164.50 million||View||N/A|
|7/18/2013||Q2 2013||$0.28||$0.36||$156.13 million||$163.80 million||View||N/A|
|4/18/2013||Q1 2013||$0.23||$0.26||$149.40 million||$153.60 million||View||N/A|
|1/30/2013||Q4 2012||$0.22||$0.27||$134.75 million||$142.80 million||View||N/A|
Earnings Estimates for Align Technology (NASDAQ:ALGN)
2017 EPS Consensus Estimate: $3.06
2018 EPS Consensus Estimate: $4.15
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Align Technology (NASDAQ:ALGN)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Align Technology (NASDAQ:ALGN)
Insider Ownership Percentage: 1.60%Insider Trades by Quarter for Align Technology (NASDAQ:ALGN)
Institutional Ownership Percentage: 81.53%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|5/31/2017||Joseph Lacob||Director||Sell||50,000||$144.98||$7,249,000.00|| |
|5/30/2017||Joseph Lacob||Director||Sell||3,874||$143.96||$557,701.04|| |
|5/30/2017||Sreelakshmi Kolli||VP||Sell||1,000||$144.00||$144,000.00|| |
|2/28/2017||Joseph Lacob||Director||Sell||50,000||$102.67||$5,133,500.00|| |
|2/24/2017||Christopher C Puco||VP||Sell||24,353||$101.88||$2,481,083.64|| |
|2/22/2017||Thomas M Prescott||Director||Sell||66,528||$101.12||$6,727,311.36|| |
|2/15/2017||Andrea Lynn Saia||Director||Sell||4,000||$99.68||$398,720.00|| |
|2/3/2017||C Raymond Larkin Jr||Director||Sell||15,000||$94.71||$1,420,650.00|| |
|11/29/2016||Jennifer Olson||VP||Sell||3,662||$95.44||$349,501.28|| |
|11/29/2016||Warren S Thaler||Director||Sell||8,500||$95.57||$812,345.00|| |
|11/18/2016||David L White||CFO||Sell||11,152||$95.53||$1,065,350.56|| |
|11/14/2016||Thomas M Prescott||Director||Sell||33,125||$90.60||$3,001,125.00|| |
|8/29/2016||Jennifer Olson||VP||Sell||799||$93.30||$74,546.70|| |
|8/15/2016||Zelko Relic||VP||Sell||13,577||$95.91||$1,302,170.07|| |
|8/9/2016||Julie Tay||VP||Sell||3,000||$92.60||$277,800.00|| |
|5/23/2016||George J Morrow||Director||Sell||50,000||$77.72||$3,886,000.00|| |
|5/16/2016||Raphael Pascaud||VP||Sell||3,000||$77.00||$231,000.00|| |
|5/10/2016||Julie Tay||VP||Sell||1,250||$77.00||$96,250.00|| |
|5/5/2016||C Raymond Larkin Jr||Director||Sell||15,000||$74.36||$1,115,400.00|| |
|5/5/2016||Roger E George||VP||Sell||27,311||$75.00||$2,048,325.00|| |
|5/3/2016||Julie Tay||VP||Sell||1,754||$75.00||$131,550.00|| |
|5/3/2016||Thomas M Prescott||Director||Sell||64,773||$74.54||$4,828,179.42|| |
|2/25/2016||Christopher C Puco||VP||Sell||11,413||$63.51||$724,839.63|| |
|2/23/2016||Timothy A. Mack||VP||Sell||28,384||$63.25||$1,795,288.00|| |
|2/22/2016||Christopher C. Puco||VP||Sell||6,278||$64.01||$401,854.78|| |
|2/4/2016||Greg J Santora||Director||Sell||9,000||$67.28||$605,520.00|| |
|1/5/2016||David C Nagel||Director||Sell||1,100||$64.64||$71,104.00|| |
|12/14/2015||David C Nagel||Director||Sell||1,100||$65.20||$71,720.00|| |
|11/2/2015||Julie Tay||VP||Sell||1,500||$66.67||$100,005.00|| |
|10/30/2015||Emory Wright||VP||Sell||25,272||$65.04||$1,643,690.88|| |
|10/28/2015||Jennifer Erfurth||VP||Sell||6,198||$66.04||$409,315.92|| |
|10/27/2015||David L. White||CFO||Sell||8,426||$66.85||$563,278.10|| |
|10/27/2015||Greg J. Santora||Director||Sell||20,000||$66.95||$1,339,000.00|| |
|8/25/2015||Andrea Lynn Saia||Director||Sell||3,567||$55.10||$196,541.70|| |
|8/20/2015||Warren S. Thaler||Director||Sell||7,000||$58.75||$411,250.00|| |
|8/17/2015||Thomas M Prescott||Director||Sell||40,000||$60.50||$2,420,000.00|| |
|5/15/2015||Jennifer Erfurth||VP||Sell||2,400||$59.27||$142,248.00|| |
|5/7/2015||C Raymond Larkin Jr||Director||Sell||15,000||$59.03||$885,450.00|| |
|5/6/2015||Warren S Thaler||Director||Sell||7,000||$58.75||$411,250.00|| |
|5/5/2015||David L White||CFO||Sell||1,899||$59.37||$112,743.63|| |
|5/5/2015||John Patrick Graham||CMO||Sell||1,139||$60.37||$68,761.43|| |
|5/5/2015||Timothy A Mack||VP||Sell||28,280||$59.47||$1,681,811.60|| |
|5/1/2015||Roger E George||VP||Sell||23,248||$58.69||$1,364,425.12|| |
|2/26/2015||Raphael Pascaud||VP||Sell||6,500||$56.40||$366,600.00|| |
|2/24/2015||Christopher C Puco||VP||Sell||11,982||$56.40||$675,784.80|| |
|11/4/2014||Timothy A Mack||VP||Sell||9,375||$52.17||$489,093.75|| |
|10/28/2014||C Raymond Larkin Jr||Director||Sell||15,000||$51.54||$773,100.00|| |
|10/28/2014||Jennifer Erfurth||VP||Sell||6,242||$52.25||$326,144.50|| |
|8/27/2014||Roger E George||VP||Sell||10,875||$55.85||$607,368.75|| |
|8/21/2014||David L White||CFO||Sell||4,600||$54.42||$250,332.00|| |
|8/21/2014||John Patrick Graham||CMO||Sell||7,046||$54.41||$383,372.86|| |
|8/19/2014||Thomas M Prescott||CEO||Sell||14,896||$55.07||$820,322.72|| |
|5/29/2014||Timothy A Mack||VP||Sell||16,333||$55.06||$899,294.98|| |
|5/1/2014||Raphael Pascaud||VP||Sell||2,000||$50.79||$101,580.00|| |
|2/25/2014||Christopher Puco||VP||Sell||4,462||$54.09||$241,349.58|| |
|2/24/2014||Roger George||VP||Sell||19,474||$54.23||$1,056,075.02|| |
|2/11/2014||Jennifer Erfurth||VP||Sell||3,144||$55.34||$173,988.96|| |
|2/7/2014||Thomas Prescott||CEO||Sell||236,979||$54.64||$12,948,532.56|| |
|2/4/2014||Timothy Mack||VP||Sell||12,761||$54.73||$698,409.53|| |
|2/4/2014||Warren Thaler||Director||Sell||18,000||$54.75||$985,500.00|| |
|10/31/2013||Jennifer Erfurth||VP||Sell||3,242||$56.97||$184,696.74|| |
|10/30/2013||Richard M.L. Twomey||VP||Sell||4,010||$57.05||$228,770.50|| |
|10/30/2013||Thomas M Prescott||CEO||Sell||188,176||$56.88||$10,703,450.88|| |
|10/30/2013||Warren S Thaler||Director||Sell||35,250||$56.55||$1,993,387.50|| |
|10/22/2013||George J Morrow||Director||Sell||75,000||$57.27||$4,295,250.00|| |
|10/22/2013||Thomas M Prescott||CEO||Sell||74,513||$58.00||$4,321,754.00|| |
|8/29/2013||Richard M.L. Twomey||VP||Sell||2,135||$43.76||$93,427.60|| |
|8/29/2013||Timothy Mack||SVP||Sell||18,477||$43.32||$800,423.64|| |
|8/9/2013||Joseph Lacob||Director||Sell||8,000||$43.85||$350,800.00|| |
|8/1/2013||Greg Santora||Director||Sell||16,000||$43.79||$700,640.00|| |
|7/30/2013||Warren S Thaler||Director||Sell||10,000||$42.24||$422,400.00|| |
|7/25/2013||Roger E George||VP||Sell||26,252||$43.55||$1,143,274.60|| |
|7/24/2013||Richard M.L. Twomey||VP||Sell||4,532||$43.42||$196,779.44|| |
|5/31/2013||Joseph Lacob||Director||Sell||49,998||$36.16||$1,807,927.68|| |
|5/15/2013||Richard M.L. Twomey||VP||Sell||1,875||$36.10||$67,687.50|| |
|2/4/2013||Len Hedge||SVP||Sell||100,000||$31.38||$3,138,000.00|| |
|11/12/2012||Dan Scott Ellis||VP||Sell||18,815||$26.52||$498,973.80|| |
|8/9/2012||Joseph Lacob||Director||Sell||300,000||$34.97||$10,491,000.00|| |
Headline Trends for Align Technology (NASDAQ:ALGN)
Latest Headlines for Align Technology (NASDAQ:ALGN)
Loading headlines, please wait.
Align Technology (ALGN) Chart for Sunday, October, 22, 2017